310 related articles for article (PubMed ID: 35445690)
1. Impact of Vaccination and Early Monoclonal Antibody Therapy on Coronavirus Disease 2019 Outcomes in Organ Transplant Recipients During the Omicron Wave.
Solera JT; Árbol BG; Alshahrani A; Bahinskaya I; Marks N; Humar A; Kumar D
Clin Infect Dis; 2022 Dec; 75(12):2193-2200. PubMed ID: 35445690
[TBL] [Abstract][Full Text] [Related]
2. Outcomes of bebtelovimab and sotrovimab treatment of solid organ transplant recipients with mild-to-moderate coronavirus disease 2019 during the Omicron epoch.
Yetmar ZA; Beam E; O'Horo JC; Seville MT; Brumble L; Ganesh R; Razonable RR
Transpl Infect Dis; 2022 Aug; 24(4):e13901. PubMed ID: 35848574
[TBL] [Abstract][Full Text] [Related]
3. COVID-19 Infection With the Omicron SARS-CoV-2 Variant in a Cohort of Kidney and Kidney Pancreas Transplant Recipients: Clinical Features, Risk Factors, and Outcomes.
Wong G; Rowlandson M; Sabanayagam D; Ginn AN; Kable K; Sciberras F; Au E; Draper J; Arnott A; Sintchenko V; Dwyer DE; Chen SCA; Kok J
Transplantation; 2022 Sep; 106(9):1860-1866. PubMed ID: 35675438
[TBL] [Abstract][Full Text] [Related]
4. Is the Omicron variant truly less virulent in solid organ transplant recipients?
Anjan S; Khatri A; Viotti JB; Cheung T; Garcia LAC; Simkins J; Loebe M; Phancao A; O'Brien CB; Sinha N; Ciancio G; Vianna RM; Andrews D; Abbo LM; Guerra G; Natori Y
Transpl Infect Dis; 2022 Dec; 24(6):e13923. PubMed ID: 35915957
[TBL] [Abstract][Full Text] [Related]
5. Reduction in the risk of progression of solid organ transplant recipients infected by SARS-CoV-2 treated with monoclonal antibodies.
Candel FJ; Salavert M; Lorite Mingot D; Manzano Crespo M; Pérez Portero P; Cuervo Pinto R
Rev Esp Quimioter; 2023 Aug; 36(4):380-391. PubMed ID: 37089055
[TBL] [Abstract][Full Text] [Related]
6. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
[TBL] [Abstract][Full Text] [Related]
7. Decline in Antibody Concentration 6 Months After Two Doses of SARS-CoV-2 BNT162b2 Vaccine in Solid Organ Transplant Recipients and Healthy Controls.
Hamm SR; Møller DL; Pérez-Alós L; Hansen CB; Pries-Heje MM; Heftdal LD; Hasselbalch RB; Fogh K; Madsen JR; Almagro Armenteros JJ; Knudsen AD; Poulsen JR; Frikke-Schmidt R; Hilsted LM; Sørensen E; Ostrowski SR; Harboe ZB; Perch M; Sørensen SS; Rasmussen A; Bundgaard H; Garred P; Iversen K; Nielsen SD
Front Immunol; 2022; 13():832501. PubMed ID: 35281023
[TBL] [Abstract][Full Text] [Related]
8. Relationship Between Immune Response to Severe Acute Respiratory Syndrome Coronavirus 2 Vaccines and Development of Breakthrough Infection in Solid Organ Transplant Recipients: The CONTRAST Cohort.
Bonazzetti C; Tazza B; Gibertoni D; Pasquini Z; Caroccia N; Fanì F; Fornaro G; Pascale R; Rinaldi M; Miani B; Gamberini C; Morelli MC; Tamé M; Busutti M; Comai G; Potena L; Borgese L; Salvaterra E; Lazzarotto T; Scudeller L; Viale P; Giannella M;
Clin Infect Dis; 2023 May; 76(10):1761-1767. PubMed ID: 36636955
[TBL] [Abstract][Full Text] [Related]
9. Short-course early outpatient remdesivir prevents severe disease due to COVID-19 in organ transplant recipients during the omicron BA.2 wave.
Solera JT; Árbol BG; Bahinskaya I; Marks N; Humar A; Kumar D
Am J Transplant; 2023 Jan; 23(1):78-83. PubMed ID: 36148607
[TBL] [Abstract][Full Text] [Related]
10. Monoclonal Antibody Therapy in Kidney Transplant Recipients With Delta and Omicron Variants of SARS-CoV-2: A Single-Center Case Series.
Fernandes G; Devresse A; Scohy A; De Greef J; Yombi JC; Belkhir L; Darius T; Mourad M; Buemi A; Kabamba B; Goffin E; Kanaan N
Kidney Med; 2022 Jun; 4(6):100470. PubMed ID: 35493029
[TBL] [Abstract][Full Text] [Related]
11. Vaccine Effectiveness Against the SARS-CoV-2 B.1.1.529 Omicron Variant in Solid Organ and Islet Transplant Recipients in England: A National Retrospective Cohort Study.
Callaghan CJ; Curtis RMK; Mumford L; Whitaker H; Pettigrew G; Gardiner D; Marson L; Thorburn D; White S; Parmar J; Ushiro-Lumb I; Manas D; Ravanan R;
Transplantation; 2023 May; 107(5):1124-1135. PubMed ID: 36727724
[TBL] [Abstract][Full Text] [Related]
12. Favorable outcomes of COVID-19 in vaccinated hematopoietic stem cell transplant recipients: A single-center experience.
Tan JY; Wee LE; Tan YH; Conceicao EP; Lim FWI; Chen Y; Than H; Quek JKS; Nagarajan C; Goh YT; Hwang WYK; Phua GC; Chung SJ; Tan TT; Linn YC; Ho AYL; Tan BH
Transpl Infect Dis; 2023 Jun; 25(3):e14024. PubMed ID: 36715661
[TBL] [Abstract][Full Text] [Related]
13. mRNA Vaccine Effectiveness Against Coronavirus Disease 2019 Hospitalization Among Solid Organ Transplant Recipients.
Kwon JH; Tenforde MW; Gaglani M; Talbot HK; Ginde AA; McNeal T; Ghamande S; Douin DJ; Casey JD; Mohr NM; Zepeski A; Shapiro NI; Gibbs KW; Files DC; Hager DN; Shehu A; Prekker ME; Caspers SD; Exline MC; Botros M; Gong MN; Li A; Mohamed A; Johnson NJ; Srinivasan V; Steingrub JS; Peltan ID; Brown SM; Martin ET; Khan A; Hough CL; Busse LW; Duggal A; Wilson JG; Perez C; Chang SY; Mallow C; Rovinski R; Babcock HM; Lauring AS; Felley L; Halasa N; Chappell JD; Grijalva CG; Rice TW; Womack KN; Lindsell CJ; Hart KW; Baughman A; Olson SM; Schrag S; Kobayashi M; Verani JR; Patel MM; Self WH
J Infect Dis; 2022 Sep; 226(5):797-807. PubMed ID: 35385875
[TBL] [Abstract][Full Text] [Related]
14. Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023.
Solera JT; Árbol BG; Mittal A; Hall V; Marinelli T; Bahinskaya I; Selzner N; McDonald M; Schiff J; Sidhu A; Humar A; Kumar D
Am J Transplant; 2024 Mar; ():. PubMed ID: 38499087
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study.
Hall VG; Al-Alahmadi G; Solera JT; Marinelli T; Cardinal H; Prasad GVR; De Serres SA; Isaac D; Mainra R; Lamarche C; Sapir-Pichhadze R; Gilmour S; Matelski J; Humar A; Kumar D
Transplantation; 2022 Aug; 106(8):1622-1628. PubMed ID: 35502801
[TBL] [Abstract][Full Text] [Related]
16. Severity of COVID-19 among solid organ transplant recipients in Canada, 2020-2021: a prospective, multicentre cohort study.
Hall VG; Solera JT; Al-Alahmadi G; Marinelli T; Cardinal H; Poirier C; Huard G; Prasad GVR; De Serres SA; Isaac D; Mainra R; Lamarche C; Sapir-Pichhadze R; Gilmour S; Humar A; Kumar D
CMAJ; 2022 Aug; 194(33):E1155-E1163. PubMed ID: 36302101
[TBL] [Abstract][Full Text] [Related]
17. Outcome of lung transplant recipients infected with SARS-CoV-2/Omicron/B.1.1.529: a Nationwide German study.
Kneidinger N; Hecker M; Bessa V; Hettich I; Wald A; Wege S; Nolde AB; Oldigs M; Syunyaeva Z; Wilkens H; Gottlieb J
Infection; 2023 Jun; 51(3):749-757. PubMed ID: 36083405
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity, Safety, and Breakthrough Severe Acute Respiratory Syndrome Coronavirus 2 Infections After Coronavirus Disease 2019 Vaccination in Organ Transplant Recipients: A Prospective Multicenter Canadian Study.
Kabbani D; Yotis DM; Ferreira VH; Shalhoub S; Belga S; Tyagi V; Ierullo M; Kulasingam V; Hébert MJ; West L; Delisle JS; Racine N; De Serres SA; Cardinal H; Dieudé M; Humar A; Kumar D
Open Forum Infect Dis; 2023 May; 10(5):ofad200. PubMed ID: 37213422
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of severe acute respiratory syndrome coronavirus 2 monoclonal antibodies in high-risk solid organ transplant recipients across three major coronavirus disease 2019 variant waves.
Zeitler K; Piccicacco N; O'Neal M; Montero J; Myers A; Strebig D; Nestler S; Anger LB; Kim K
Transpl Infect Dis; 2023 Aug; 25(4):e14095. PubMed ID: 37378536
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 Reinfection Has Better Outcomes Than the First Infection in Solid Organ Transplant Recipients.
Solera JT; Árbol BG; Mittal A; Hall VG; Marinelli T; Bahinskaya I; Humar A; Kumar D
Transplantation; 2024 May; 108(5):1249-1256. PubMed ID: 38291585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
